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ABSTRACT Hepatitis A virus (HAV) is an unusual picornavirus that is released from cells cloaked in host-derived membranes.
These quasi-enveloped virions (eHAV) are the only particle type circulating in blood during infection, whereas only nonenvel-
oped virions are shed in feces. The reason for this is uncertain. Hepatocytes, the only cell type known to support HAV replication
in vivo, are highly polarized epithelial cells with basolateral membranes facing onto hepatic (blood) sinusoids and apical mem-
branes abutting biliary canaliculi fromwhich bile is secreted to the gut. To assess whether eHAV and nonenveloped virus egress
from cells via vectorially distinct pathways, we studied infected polarized cultures of Caco-2 and HepG2-N6 cells. Most (>99%)
progeny virions were released apically from Caco-2 cells, whereas basolateral (64%) versus apical (36%) release was more bal-
anced with HepG2-N6 cells. Both apically and basolaterally released virions were predominantly enveloped, with no suggestion
of differential vectorial release of eHAV versus naked virions. Basolateral to apical transcytosis of either particle type was
minimal (<0.02%/h) in HepG2-N6 cells, arguing against this as a mechanism for differences in membrane envelopment of
serum versus fecal virus. High concentrations of human bile acids converted eHAV to nonenveloped virions, whereas virus
present in bile from HAV-infected Ifnar1/ Ifngr1/ and Mavs/mice banded over a range of densities extending from
that of eHAV to that of nonenveloped virions. We conclude that nonenveloped virions shed in feces are derived from
eHAV released across the canalicular membrane and stripped of membranes by the detergent action of bile acids within
the proximal biliary canaliculus.
IMPORTANCE HAV is a hepatotropic, fecally/orally transmitted picornavirus that can cause severe hepatitis in humans. Recent
work reveals that it has an unusual life cycle. Virus is found in cell culture supernatant fluids in twomature, infectious forms:
one wrapped in membranes (quasi-enveloped) and another that is nonenveloped. Membrane-wrapped virions circulate in blood
during acute infection and are resistant to neutralizing antibodies, likely facilitating HAV dissemination within the liver. On the
other hand, virus shed in feces is nonenveloped and highly stable, facilitating epidemic spread and transmission to naive hosts.
Factors controlling the biogenesis of these two distinct forms of the virus in infected humans are not understood. Here we char-
acterize vectorial release of quasi-enveloped virions from polarized epithelial cell cultures and provide evidence that bile acids
strip membranes from eHAV following its secretion into the biliary tract. These results enhance our understanding of the life
cycle of this unusual picornavirus.
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Hepatitis A virus (HAV) is an unusual member of the Picorna-viridae family. Its capsid differs structurally from that of other
mammalian picornaviruses, with a VP2 domain swap found only
in insect-resident members of the Picornavirales (1). The capsid
also has both unusually high physical stability and a distinct as-
sembly mechanism (2, 3). Strongly hepatotropic, HAV is spread
by fecal-oral transmission and causes acute inflammatory liver
disease in humans (4). While the capsid of virus shed in feces of
infected individuals is naked and nonenveloped, virions circulat-
ing in the blood during acute infection are completely enveloped
in host-derivedmembranes that provide protection fromneutral-
izing antibodies directed against the capsid (5). These quasi-
enveloped virions (eHAV) are infectious and are similar to exo-
somes in both size and buoyant density. They share several
attributes with classical enveloped viruses, although there is no
evidence for the presence of virally encoded peplomers on their
surface (5, 6).
The mechanisms underlying the dramatic differences in the
physical characteristics of virus in the blood (where it is entirely
quasi-enveloped) versus the feces (where it is naked and nonen-
veloped) are not clear. Some data suggest that HAV undergoes
limited replication within the gastrointestinal tract (7). However,
the principal site of replication is believed to be the hepatocyte,
with the virus that is shed in feces being secreted to the gastroin-
testinal tract from the liver through the biliary system. Consistent
with this, large numbers of nonenveloped virions have been visu-
alized in the bile of experimentally infected chimpanzees (8). A
similar situation exists in mice with defects in type I interferon
signaling that are permissive for infection by human HAV (9).
Replication is restricted to hepatocytes in these mice, which have
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substantial fecal shedding of nonenveloped HAV virions despite
little if any detectable viral RNA in tissues of the small and large
intestine (9).
Hepatocytes are highly polarized cells of epithelial origin with
distinct basolateral and apical membranes and very specialized
protein export pathways (10, 11). Their basolateral membrane
faces onto the space of Disse, which communicates with blood
flowing through the hepatic sinusoids, whereas the smaller apical
membrane abuts the lumen of the biliary canaliculus (Fig. 1A).
Bile acids are secreted by hepatocytes across the apical membrane
into the canaliculus and then flow toward larger bile ductules to
eventually reach the gut (11). Tight junctions forming between
neighboring hepatocytes separate apical and basolateral mem-
branes and seal the canalicular lumen, forming a barrier between
blood and bile that prevents diffusion of bile acids and other large
solutes.
Several hypotheses can explain why quasi-enveloped eHAV vi-
rions are found in the circulation whereas nonenveloped virus is
shed from the gastrointestinal tract. The simplest explanation
would be that eHAV membranes are eliminated by the detergent
action of bile acids during passage through the biliary tract
(Fig. 1B). Previous studies have shown that the eHAVmembrane
is stable when virus is incubated for 2 h at 37°C in 98% freshly
collected porcine bile (reference 5 and unpublished observations).
However, bile acid concentrations are greater and their detergent
action is much stronger in the proximal biliary canaliculus where
bile originates, making this hypothesis a continuing possibility
(11).
An alternate hypothesis is that the two forms of the virus egress
from infected hepatocytes via distinct export pathways, with
eHAV released into the blood and nonenveloped virions into the
bile (Fig. 1C). Previous studies have shown HAV to be secreted in
a vectorial fashion from polarized epithelial cell cultures (12, 13),
but those studies did not differentiate between eHAV and nonen-
veloped virions, leaving open the possibility of differential release
of eHAV versus HAV. Yet a third hypothesis, suggested recently
by Counihan and Anderson (14), proposes that both quasi-
enveloped and nonenveloped virions are released across the baso-
lateral membrane into the space of Disse but that the naked, non-
enveloped virions subsequently reenter hepatocytes and undergo
transcytosis to the apical membrane, where they are released into
the biliary tract (Fig. 1D). Late in the course of infection, transcy-
tosis may be enhanced by IgA antibodies binding the HAV capsid
(14). While seemingly complicated, this proposed apical export
pathway mimics some aspects of the default pathway utilized by
hepatocytes for transport of apical proteins (10, 11).
Here, we describe a series of experiments in cell culture and
HAV-infected mice that showed that HAV is released across both
the basolateral and apical membranes of polarized epithelial cells
predominantly (if not exclusively) as enveloped eHAV virions.
We show that high concentrations of human bile acids effectively
convert quasi-enveloped eHAV virions to naked, nonenveloped
particles and demonstrate the presence of virions undergoing this
transition in bile collected from infected mice.
RESULTS
Vectorial release of virus from polarized Caco-2 cells. In previ-
ous studies, we found that most (~80%) virions present in super-
natant fluids of infected Huh-7.5 human hepatoma cells were
quasi-enveloped, whereas the remainder were naked, nonenvel-
oped particles (5). To determine whether differences exist in the
modes of vectorial release of these two particle types, we studied
Caco-2 cells, a human colonic adenocarcinoma-derived cell line
that is known to establish a high degree of polarity in culture and
is widely used as a model system for intestinal epithelial permea-
bility (15–17). Caco-2 cells exhibit a simple polarity consisting of
single apical and basolateral surfaces that oppose each other, and
previous work in our laboratory has shown that they release HAV
almost exclusively from the apical membrane (12).We confirmed
the polarity of cells grown on glass slides by assessing localization
FIG 1 Microanatomy of the hepatocyte and three possible explanations for the presence of different forms ofHAV in blood (quasi-enveloped) and feces (naked,
nonenveloped). (A) Simplified diagram showing two hepatocytes in relation to the space of Disse and hepatic sinusoid that is bathed in blood and to the biliary
canaliculus that encircles hepatocytes in a belt-like fashion and into which virus and bile are secreted across the hepatocyte apical membrane. Bile flows from the
canaliculus to larger bile ductules and ultimately to the lumen of the gastrointestinal tract. (B to D) Competing hypotheses that could explain differences in
membrane association and quasi-envelopment of virus in different compartments. See introductory text for details.
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of the apical membrane protein dipeptidyl-peptidase 4 (DPP4, or
CD26) and tight junction protein 1 (TJP1, or ZO-1) by confocal
immunofluorescent microscopy (Fig. 2A). TJP1 was present at
intercellular contacts, ringing the perimeter of cells in x-y sections
and thus confirming the existence of intact tight junctions
(Fig. 2A, top). In contrast, DPP4 localized exclusively to the apical
cell surface in x-z sections (Fig. 2A, bottom), confirming that the
Caco-2 cells form polarized monolayers.
To assess the integrity of Caco-2 monolayers grown on a per-
meable membrane (Transwell-COL insert), we measured the dif-
fusion of fluorescein isothiocyanate-conjugated dextran (FITC-
dextran; 500 kDa) placed in the upper (apical) chamber of the
insert into the lower (basolateral) chamber over time. In the
absence of cells, the diffusion rate was 31.3%/h (Fig. 2B). This was
reduced to 0.27%/h by the Caco-2 monolayer, which is below the
(3H)inulin (monomer mass of 5 kDa) diffusion rate of 1.0%/h
considered indicative of the formation of intact tight junctions
(16, 18). The molecular weight of a tracer is likely to influence its
diffusion rate, with high-molecular-weight tracers diffusing
slowly compared to those with low molecular weight. Since the
diameters of nonenveloped (27 nm) and quasi-enveloped (~50 to
110 nm) virions (5) are similar to or larger than that of FITC-
dextran (29 nm) (19), these results indicated that paracellular dif-
fusion was unlikely to biasmeasurements of vectorial virus release
from these cells (5).
To examine vectorial release, Caco-2 cell monolayers were api-
cally infected with HAV, as HAV entry occurs efficiently at the
apical surface of these cells (12). The virus that we used, HM175/
p16, is adapted to growth in cell culture and relatively attenuated
in its capacity to cause disease in primates and causes no detectable
cytopathic effect in cell culture (20, 21). The FITC-dextran diffu-
sion rate was not increased by infection over a period of 7 days
(Fig. 2B), indicating that barrier function was not disturbed. Api-
cal and basolateral fluids were collected daily over this period, and
the quantity of virus released into each compartment was mea-
sured by real-time quantitative PCR (RT-qPCR). Virus was re-
leased almost (99%) exclusively from the apicalmembrane dur-
ing the period of exponential growth (day 4 to day 5), reaching
5.4 107 genome equivalents (GE)/culture by day 7 (Fig. 2C). The
level of virus release across basolateral membranes rose slowly
until day 5 but then exponentially increased to 2.9  106 GE/
culture at day 6, reaching amaximumof 4.2% to 12.7%of all virus
released on days 6 to 7. These results were replicated in indepen-
dent experiments and are consistent with a previous report from
our laboratory showing thatHAV release is largely restricted to the
apical domain of Caco-2 cells (12). To determine the proportion
of quasi-enveloped eHAV virions released from apical versus ba-
solateral domains, supernatant fluids from day 6 were concen-
trated and eHAV and nonenveloped HAV populations separated
on an isopycnic gradient (seeMaterials andMethods). The density
of the quasi-enveloped virions in isopycnic iodixanol gradients is
approximately 1.08 g/cm3, whereas nonenveloped particles band
at densities greater than 1.22 g/cm3 (5). Virus released across both
the apical and basolateral membranes of Caco-2 cells banded pre-
dominantly at the density of quasi-enveloped virions (fractions 8
to 12; 1.065 to 1.115 g/cm3) (Fig. 2D). Only a small proportion of
virus banded at a density consistent with nonenveloped particles
(fractions 17 to 19; 1.213 to 1.341 g/cm3), indicating amuch lower
abundance of nonenveloped virions in these samples. It is not
clear whether these nonenveloped virions were released as such
FIG 2 HAV infection of polarized Caco-2 cell monolayers. (A) Polarity was assessed by determining the intracellular localization of DPP4 (CD26) and TJP1
(ZO-1). Cells were seeded into chamber slides and cultured for 10 days before being fixed and stained with antibodies specific for DPP4 (red) and TJP1 (green).
Nuclei were counterstained with DAPI (blue). Images of xy and xz sections were collected by confocal microscopy. z sections were compiled by taking 0.41-m
steps through each x-y section; “a” and “b” indicate approximate positions of apical and basolateralmembranes, respectively. The scale bars represent 20m. (B)
The integrity of monolayer cell cultures grown on Transwell membranes was assessed by measuring paracelluar diffusion of FITC-dextran prior to (day 0) and
7 days after virus infection. Results shown represent the mean percentage  range of FITC-dextran delivered to the apical chamber that was detected in the
basolateral chamber 60min later (seeMaterials andMethods). (C)Vectorial release of quasi-envelopedHAV frompolarizedCaco-2 cells. After 14 days of culture
on Transwell inserts, cells were infected by inoculating the apical surface with HAV. Total apical and basolateral fluids were collected at 24-h intervals, and HAV
RNA was quantified by RT-qPCR. (D) The buoyant density of virus particles present in the apical (top) and basolateral (bottom) compartments of Transwell
cultures on day 6 of the infection was determined by centrifugation in isopycnic iodixanol gradients followed by HAV-specific RT-qPCR.
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from the cells or were derived from eHAV particles that had sus-
tained loss of the enveloping membrane during concentration by
ultrafiltration followed by high-speed centrifugation through an
iodixanol gradient.
Vectorial release of virus from polarized HepG2-N6 cells.
The N6 clone of the HepG2 human hepatocellular carcinoma cell
line (HepG2-N6 cells) has been reported to exhibit simple polar-
ity, with single apical and basolateral surfaces that oppose each
other, and to support vectorial release of HAV (13, 22). However,
unlike Caco-2 cells, which release virus apically, these cells were
reported to release HAV predominantly across the basolateral
membrane (13). To confirm polarity, HepG2-N6 cells were cul-
tured on glass slides for 17 days and then stained for DPP4 and
TJP1 (Fig. 3A). As with the polarized Caco-2 cells, DPP4 was lo-
calized to the apical cell surface, while TJP1 displayed a ring-like
pattern in xy sections. By light microscopy, there was no sugges-
tion of the formation of the biliary canaliculus-like cysts or
ductules which the apical surfaces of adjacent cells form in pri-
mary hepatocytes and those of differentiated hepatic cell lines
form in culture (10), although this has been reported for HepG2
cells previously (23). These results confirm that HepG2-N6 cells
form simple polarized monolayers with a columnar orientation
not dissimilar from that of Caco-2 cells. The rate of FITC-dextran
diffusion was only 0.30%/h across HepG2-N6 monolayers grown
on Transwell inserts and was not increased byHAV infection over
a 4-day period (Fig. 3B).
HepG2-N6 cell monolayers were infected with HAV via the
basolateral rather than the apical membrane, since HAV report-
edly enters HepG2-N6 cells more efficiently via this domain (13).
Apical and basolateral fluids were collected daily for 4 days, and
the quantity and type of virus present in each compartment were
assessed as described for the Caco-2 cells. Replication was much
less efficient than inCaco-2 cells, with lowermaximal yields (com-
pare Fig. 3C with Fig. 2C). Increasing amounts of virus were re-
leased into the basolateral fluid continuously from day 1, whereas
an increase in apically released virus did not begin until day 2
(Fig. 3C). This delay in apical virus release was reproduced in an
independent, repeat experiment. At 1 day after infection, 87.5%of
all released virus was directed into basolateral culture fluids, con-
sistent with the report by Snooks et al. (13) that virus is predom-
inantly (over 90%) secreted from the basolateral membrane of
HepG2-N6 cells. Virus release was more balanced on day 2 and
thereafter, although there was always greater release into the ba-
solateral rather than the apical compartment (mean, 64% versus
36%; P 0.001 by two-way analysis of variance [ANOVA]).
We collected day 4 culture supernatants to assess the buoyant
density of the extracellular virus. Virus present in both apical and
basolateral compartments was again predominantly enveloped
(80.5% and 77.5%, respectively), banding at a density of 1.064 to
1.125 g/cm3 (fractions 9 to 13) (Fig. 3D). However, in contrast to
the Caco-2 cells, a substantial minor population of nonenveloped
virions was present in both compartments (fraction 18; 1.261 g/
cm3). The relative proportions of quasi-enveloped versus nonen-
veloped virions were equivalent in the apical and basolateral com-
partments of the HepG2-N6 cultures (Fig. 3D). Collectively, these
results argue against the hypothesis that eHAV and nonenveloped
HAVparticles are released from cells via vectorially distinct export
pathways (Fig. 1C).
The reproducible 1-day delay that we observed in apical release
of HAV from polarized cultures of HepG2-N6 cells (Fig. 3C) sug-
gested the possibility that apical viral egress might result from
transcytosis of virions released into the basolateral compartment
(Fig. 1D). To assess this possibility, we added either gradient-
purified eHAV or nonenveloped virions to the basolateral com-
FIG 3 HAV infection of polarized HepG2-N6 cell monolayers. (A) Polarity was assessed by determining the intracellular localization of DPP4 and TJP1. Cells
were cultured for 17 days before being fixed and stained with specific antibodies. See the legend to Fig. 1A for additional details. (B) Paracellular diffusion of
FITC-dextran in monolayer cultures of HepG2-N6 cells. See the legend to Fig. 2B for details. (C) Vectorial release of virus from HepG2-N6 cells. Cells were
infected at the basolateral surface after 18 days culture on Transwell membranes. Total apical and basolateral fluids were subsequently collected at 24-h intervals.
HAVRNAwas quantified byRT-qPCR. (D) Buoyant densities of virions present in the apical (top) and basolateral (bottom) compartments of Transwell cultures
4 days after infection. (E) Basolateral to apical compartment transcytosis of nonenveloped (“naked”) and enveloped eHAV virions by HepG2-N6 cells.
Gradient-purified HAV and eHAV (1 108 GE) were added to the basolateral compartment of polarized cultures of HepG2-N6 cells maintained at either 36°C
or 4°C. Virus released into the apical chamber at hourly intervals was quantified by HAV-specific RT-qPCR. Results are shown as the mean percentage range
of virus added to the basolateral chamber that underwent transcytosis in duplicate cultures during the period indicated. BLD, below the level of detection.
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partment of polarized HepG2-N6 monolayers grown on Trans-
well inserts and then measured the transport of virus into the
apical compartment over the ensuing 3 h (seeMaterials andMeth-
ods). Somewhat greater amounts of virus were recovered from the
apical compartment when cells were incubated at 36°C versus 4°C
(P 0.065 by two-sidedMann-Whitney test) (Fig. 3E), consistent
with a low level of energy-dependent transcytosis. Overall, how-
ever, there was very limited basolateral to apical transport of HAV
under these conditions and there were no significant differences
between eHAV and nonenveloped virions (Fig. 3E). The maxi-
mum basolateral to apical transport of virus was observed with
eHAV at between 0 and 1 h, but the virus released into the apical
compartment represented only 0.015% of the virus added to the
basolateral compartment. We conclude from these results that
basolateral to apical transcytosis of HAV, while possibly present,
does not contribute significantly to the release of virus from apical
membranes of polarized HepG2-N6 cells.
Bile acid treatment of eHAV. In previous studies, the buoyant
density of eHAV was not altered by incubation in 90% to 98%
porcine bile for 2 h at 37°C (reference 5 and unpublished data).
However, these conditions poorly recapitulate those on the lumi-
nal side of the apical canalicularmembrane of human hepatocytes
across which both bile acids and virus are transported (10, 11)
(Fig. 1A). Although never measured because of anatomical con-
straints, the concentration and hence detergent action of bile acids
is greatest on the luminal surface of the canalicular membrane.
Surrounding hepatocytes in a belt-like manner, the apical mem-
brane is rich in sphingomyelin, relatively resistant to the detergent
action of bile acids, and highly active metabolically. Bile acids
secreted across the membrane by apical transporter proteins are
progressively diluted, and their detergent action is buffered by
water and phospholipid secretion, leading to micelle formation.
Moreover, the concentrations and types of bile acids secreted dif-
fer considerably among mammalian species and are different in
humans and pigs (24). We therefore assessed the stability of the
quasi-envelope of eHAV in the presence of physiologically rele-
vant concentrations of chenodeoxycholic acid (CDCA) and tau-
rocholic acid (TCA), the most abundant bile acids present in hu-
man bile (11, 24). Gradient-purified eHAV was incubated in
24 mM CDCA, 93 mM TCA, or solvent control (10% dimethyl
sulfoxide [DMSO]) for 2 h at 37°C, and its buoyant density was
then determined by isopycnic ultracentrifugation in iodixanol
gradients. Compared to the solvent control results, CDCA treat-
ment induced a shift in the peak location of eHAV in the gradients
from fractions 9 and 10 (1.072 to 1.087 g/cm3) to fractions 12 and
13 (1.148 to 1.154 g/cm3) (Fig. 4A). TCA treatment induced a
more pronounced shift to fractions 13 to 15 (1.146 to 1.175 g/
cm3). Thus, concentrations of bile acids typical of human bile
significantly increase the buoyant density of eHAV, consistent
with partial disruption of the membranes enveloping the virus. A
FIG4 Stability of quasi-enveloped eHAV in humanbile acids. (A)Quasi-enveloped eHAVvirionswere incubatedwith chenodeoxycholic acid (CDCA; 24mM),
taurocholic acid (TCA; 93mMor 930mM), or DMSO (10%) at 37°C for 2 h. The virus was then centrifuged to equilibrium in isopycnic iodixanol gradients. The
buoyant density of virions was determined by measuring the quantity of HAV RNA in fractions 6 to 19 by RT-qPCR. The distribution of virus in the
DMSO-treated samplematched that of virus incubated in PBS alone (not shown). The shaded zone indicates the expected density of nonenvelopedHAV virions.
(B) HAV capsid antigen ELISA of gradient-purified eHAV following treatment with bile acids. Virus samples (approximately 2  107 GE) were subjected to
diafiltration to remove bile acids and then tested for the presence of detectable (exposed) capsid antigen by ELISA (see Materials and Methods). (C) Infectivity
of eHAV following treatment with bile acids. Samples were subjected to diafiltration to remove bile acids and then diluted and inoculated onto FRhK-4 cells for
IR-FIFA. The content of the 102 dilution of the CDCA-treated sample was 3.8 104 GE/ml, that of the 102 dilution of the TCA-treated sample was 3.1 104
GE/ml, that of the 102 dilution of theDMSO-treated sample was 2.3 104 GE/ml, and that of the 102 dilution of the PBS-treated sample was 3.6 104 GE/ml.
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higher concentration of TCA (930 mM) fully converted quasi-
enveloped eHAV to the density of nonenveloped virions (frac-
tions 17 and 18; 1.227 to 1.283 g/cm3). Viral capsid antigen was
detected by enzyme-linked immunosorbent assay (ELISA) in
eHAV preparations after but not before treatment with CDCA
(24 mM) or TCA (93 mM), indicating that the eHAV membrane
was destroyed by the bile acids (Fig. 4B). We also assessed the
infectivity of the virus after such treatment, removing the bile
acids by diafiltration prior to titration by infrared fluorescent im-
munofocus assay (IR-FIFA). Despite their effect on buoyant den-
sity, these concentrations of CDCA and TCA did not reduce the
infectivity of eHAV (Fig. 4C).
Buoyant density of virions in bile from HAV-infected mice.
The recent discovery that wild-type human HAV replicates effi-
ciently in Ifnar1/ and Mavs/ mice has made it possible to
study the trafficking of virus in a readily accessible small-animal
model (9). Infected Ifnar1/mice, lacking expression of the type
1 interferon receptor, develop acute hepatic inflammation associ-
ated with hepatocellular apoptosis and elevated serum alanine
aminotransferase (ALT) activity, whereas infected Mavs/mice
replicate the virus to higher levels but show no evidence of disease
(9). Viral replication appears to be limited to hepatocytes in both
knockouts (KOs). Abundant virus is shed in the feces of both
infected Ifnar1/ and infected Mavs/ mice. This is likely to
occur via biliary secretion, as in humans and chimpanzees, be-
cause very little if any viral RNA can be detected in ileal or colonic
tissues. As in primates, the virus shed in feces by infected mice is
entirely nonenveloped (1.230 g/cm3) (9).
To ascertain whether mice express host factors essential for
eHAV biogenesis, we studied AML12 cells (25). These are derived
from hepatocytes of mice transgenic for human transforming
growth factor alpha (TGF-) and support replication of human
HAV. Virus present in supernatant fluids of infected AML12 cul-
tures was predominantly quasi-enveloped, with 88.6%of the virus
banding at a density of ~1.087 g/cm3 in an iodixanol gradient
(Fig. 5A). This closely matches the density of eHAV released from
human hepatocyte cultures (Fig. 3D). Since TGF- is unlikely to
be involved in eHAV biogenesis, this indicates that mice express
host factors required for eHAV biogenesis. Consistent with this,
we found previously that virus recovered from extracts of infected
mouse liver is predominantly membrane associated, possessing a
buoyant density (~1.125 g/cm3) only slightly greater than that of
eHAV in chimpanzee serum (9).
Wenext sought to characterize the buoyant densities of virus in
murine serum (originating from the basolateral membrane of
hepatocytes). We studied virus in serum from infected Mavs/
mice, collected prior to the development of anti-HAV antibody.
These knockouts do not develop hepatic inflammation or ALT
elevations and thusmimic the asymptomatic, prodromal phase of
hepatitis A in humans when eHAV circulates in blood (5). Sur-
prisingly, these results suggested the presence of two distinct virus
populations: a minor population banding at a density similar to
that of eHAV in chimpanzee serum (fractions 11 to 13; 1.105 g/
cm3) and a larger population banding at a density intermediate
between that of eHAV and naked HAV particles (fractions 15 to
18; 1.167 g/cm3) (Fig. 5B, top). Virus in serum from infected
FIG 5 Buoyant densities of virions in serum and bile from infected Mavs/ mice. (A) Supernatant fluids from infected AML12 cells were concentrated by
filtration and subjected to iodixanol density gradient centrifugation. The buoyant density of virions was determined by measuring the quantity of HAV RNA in
fractions by RT-qPCR. (B) Buoyant densities of virus circulating in blood ofMavs/mice 14 to 28 days after infection (top) and in bile from the gallbladder of
Mavs/mice 7 days after infection (middle). Also included for reference are the previously published density of virus in feces of an infectedDKOmouse (9) and
previously published densities of virus in chimpanzee samples (red) (5) (bottom).
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Ifnar1/ Ifngr1/ (double knockout [DKO]) mice also banded
predominantly at this intermediate density (see Fig. S1A in the
supplemental material). Importantly, like eHAV, virions with in-
termediate density are still significantly less dense than HAV
found in feces (Fig. 5B, bottom) and are thus likely to be associated
withmembranes. Surprisingly, however, treatment of virus recov-
ered from the blood of infectedDKOmice with 1%NP-40 did not
alter its buoyant density in iodixanol gradients (see Fig. S1A). The
nature of these virions is thus uncertain. We cannot exclude the
possibility that they were derived from quasi-enveloped virions
damaged by shearing forces during blood collection or centrifu-
gation. However, explanations other than partial loss of the envel-
oping membrane need to be considered (see Discussion). The
presence of a substantial virus “tail” in a gradient loaded with
serum from an infected chimpanzee suggests that a small propor-
tion (fractions 14 to 16) of virus circulating in chimpanzees may
possess a similar intermediate density (Fig. 5B, top).
We similarly characterized the buoyant densities of virus pres-
ent in samples of bile collected from the gallbladders of infected
mice. This virus had been secreted across the apical hepatocellular
membrane. Although virus in bile from infected Mavs/ mice
banded over a range of densities, the greatest HAV RNA content
was found in fractions with the density of naked, nonenveloped
virions (fractions 18 and 19; 1.287 g/cm3) (Fig. 5B, middle). Virus
in bile from infected DKOmice was similar, with the largest peak
at 1.275 g/cm3 (see Fig. S1B). These density profiles resemble the
patterns observed with bile acid treatment of gradient-purified
eHAV (Fig. 4A) and are consistent with conversion of quasi-
enveloped eHAV particles secreted into the bile to nonenveloped
virions following exposure to the detergent action of bile acids in
the canalicular lumen (Fig. 1B).
DISCUSSION
Most evidence suggests that the major site of HAV replication is
the liver, with virus shed in feces being produced in infected hepa-
tocytes and released into the duodenum via the biliary system (7,
26–28). Our recent studies of HAV infection in mice with defec-
tive innate immunity provide additional support for this view (9).
Viral RNA was detected only within the liver, where it was local-
ized in hepatocytes, and not in the ileum or colon. We show here
that virus circulating in the blood of thesemice bands in iodixanol
gradients at a significantly lower buoyant density than the naked,
nonenveloped virus shed in feces, indicating that it is likely to be
membrane associated (Fig. 5B, top; see also Fig. S1A in the sup-
plemental material). Such virus is released into the circulation
across the basolateral membrane of the murine hepatocyte. How-
ever, it was surprising to find two apparently distinct populations
of virions in serum from infected Mavs/ mice: one with the
density of eHAV in human and chimpanzee blood (~1.10 g/cm3)
and a second, larger population with a density (~1.16 g/cm3) in-
termediate between those of eHAV and naked virions (1.22 g/
cm3). As mentioned above, this could have resulted from phys-
ical damage sustained by eHAV particles, during either the
collection of blood or ultracentrifugation. Strikingly, treat-
ment of intermediate-density virus from DKO mice with 1%
NP-40 did not alter its density in iodixanol gradients (see
Fig. S1A). These results are reminiscent of our previously pub-
lished finding that NP-40 treatment of cell culture-derived eHAV
does not fully shift its density to that of naked virions but rather
shifts it to a similar intermediate density (1.15 to 1.17 g/cm3) (5).
These results may be explained by the association of virus with
cholesterol- and sphingolipid-rich, detergent-insoluble mem-
brane microdomains (“lipid rafts”) (29). Importantly, exosomes
appear to be enriched in such detergent-resistant membranes
(DRM) (30, 31) and are likely to possess a mechanism of biogen-
esis similar to that of eHAV (6). An alternative possibility is that
eHAV circulating in mice could bind serum proteins in a species-
specific fashion. Additional studies, including detailed proteomic
and lipidomic analyses, will be needed to fully characterize these
intermediate-density virions.
In contrast to the more buoyant, membrane-associated virus
present in serum, virus shed in feces by infected mice bands in
iodixanol gradients at the buoyant density of naked picornaviral
virions, thus recapitulating the situation in infected primates
(Fig. 5B) (5, 9). A clear explanation for this difference in the buoy-
ant density and membrane association of HAV particles in blood
and feces has been lacking. The studies we describe here address
three hypothetical explanations for this difference (Fig. 1B to D).
One possibility is that quasi-enveloped eHAV and naked, non-
envelopedHAV virions egress from polarized hepatocytes via dis-
tinct export pathways: eHAV across basolateral membranes into
the space of Disse (and thence into blood) and HAV across the
apical membrane into bile (Fig. 1C). We have never favored such
an explanation, as there is no definitive evidence for noncytolytic
egress of nonenveloped HAV virions. Such virions always com-
prise a minor fraction of the virus found in supernatant fluids of
infected cells and in some experiments are present in very small
quantities (Fig. 2D). The exosome-like egress of eHAV from cells
provides a mechanism for the proteinaceous viral capsid to tra-
verse an intact plasma membrane. Poliovirus and other distantly
related picornaviruses may exit cells in membranous blebs
through a process of secretory autophagy (32). In contrast, there is
no clear mechanism for egress of nonenveloped virus other than
cell lysis. Thus, it seems likely that the relatively small numbers of
nonenveloped virions found in cell culture supernatant fluids are
derived from quasi-enveloped virions that have lost their mem-
branes or from otherwise unapparent cell lysis.
To formally test the hypothesis that quasi-enveloped and non-
enveloped forms of HAV undergo differential vectorial release
from infected cells, we studied two previously describedmodels of
HAV infection in polarized cells. We confirmed previous studies
showing that HAV is released almost exclusively from the apical
membrane of polarized Caco-2 cells that are of gastrointestinal
epithelial origin (Fig. 2C) (12). Almost all virus present in both
apical and basolateral compartments of infected Transwell cul-
tures of Caco-2 cells was quasi-enveloped (Fig. 2D). In contrast,
after an initial delay of 24 h, we found that virus was released in a
relatively balanced fashion fromboth apical and basolateralmem-
branes of polarized HepG2-N6 cells that were of hepatocellular
origin (Fig. 3C). These results differ somewhat from those of
Snooks et al. (13), who reported that 95% of virions were released
from the basolateral membrane of HepG2-N6 cells. This differ-
ence not withstanding, virus present in either compartment was
again predominantly quasi-enveloped (Fig. 3D). Unlike Caco-2-
derived virus, a small but distinct population of nonenveloped
virionswas present in both compartments ofHepG2-N6 cells. The
ratios of naked virions to quasi-enveloped virions were similar in
the two compartments. It is interesting to speculate that the small
fraction of nonenveloped virus (mostly absent in Caco-2 superna-
tants) might have been due to secretion of bile acids by these
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relatively well-differentiated hepatocytes (see below). Collec-
tively, however, the data indicate that quasi-enveloped and non-
enveloped HAV do not have vectorially distinct export pathways
and thus argue against the hypothesis proposed in Fig. 1C.
Protein transport to the canalicular membrane is complex in
hepatocytes, with glycosylphosphatidylinositol (GPI)-anchored
and single-pass apical membrane proteins transported first to the
basolateral membrane prior to undergoing transcytosis to the
canalicular (apical) membrane (10, 33). It is likely that the unique
nature of membrane protein trafficking in hepatocytes accounts
for the differences observed in vectorial release of HAV in Caco-2
(derived from colonic epithelium) and HepG2-N6 (hepatocyte-
derived) cell lines (12, 13). It is possible that use of the default
hepatocyte export pathway might account for the reproducible
delay that we observed in the apical release of eHAV from infected
HepG2-N6 cells (Fig. 3C). Counihan and Anderson (14) have
proposed recently that selective transcytosis of naked versus
quasi-enveloped virions could result in apical release of naked
virus by hepatocytes following initial secretion from the basolat-
eral membrane (Fig. 1D). However, our data show an absence of
selectivity and only a very limited capacity to mediate the transcy-
tosis of either naked or quasi-enveloped HAV from basolateral to
apical membranes of polarized HepG2-N6 cells (Fig. 3E). IgA an-
tibodies specific for HAV have been shown to enhance both hep-
atocellular uptake and transcytosis of HAV (14, 34), but these
antibodies develop late in the course of hepatitis A and are asso-
ciated with a decrease, not an increase, in fecal shedding of virus
(4, 35, 36). We conclude that hepatocellular transcytosis is un-
likely to contribute materially to the fecal shedding of HAV.
This leaves the third hypothesis for consideration: that eHAV,
secreted across the apical hepatocyte membrane into the biliary
canaliculus, is stripped of its membranes by the detergent actions
of bile acids (Fig. 1B). Early studies by Schulman et al. (8) found
that virus in the bile (gallbladder aspirate) of experimentally in-
fected chimpanzees had both the morphology and the density
of nonenveloped virions (1.29 to 1.34 g/cm3 in CsCl). However,
immune electron microscopy (IEM) was used to detect virus in
those studies, and that would not have detected quasi-enveloped
virions (5). Thus, while nonenveloped virions are well docu-
mented in bile, the possibility of the simultaneous presence of
quasi-enveloped eHAV has not been excluded. Although our pre-
vious studies showed that eHAV is stable in porcine bile (5), it is
important that this experiment did not reproduce the conditions
to which HAV would be exposed in the proximal biliary canalic-
ulus. Following secretion, bile acids are rapidly incorporated into
mixedmicelles, with phospholipids released from the luminal side
of the canalicular membrane (11, 37). These phospholipids neu-
tralize the detergent action of the bile acids, which is further re-
duced by the dilutional effects of water secretion during passage
through the biliary system. Thus, detergent action is greatest at the
luminal surface of the canalicular membrane across which both
virus and bile acids are transported. Local concentrations of bile
acids have never been measured at the luminal surface of the can-
alicular membrane (which must be traversed by HAV to gain ac-
cess to the bile), but are likely to be very high.
The integrity of the eHAV membrane is destroyed by 1% NP-
40. Capsid antigen can be detected by ELISA after such treatment,
despite the fact that the density of the virus increases to only 1.15
to 1.17 g/cm3 as mentioned above (5). This matches the density of
eHAVparticles after suspension in a 93mMconcentration of TCA
(Fig. 4A), a principal component of human bile (38). Thus, bile
acids present in human bile are as effective as 1% NP-40 in de-
stroying the integrity of the envelope. In contrast, 930 mM TCA
promotes complete conversion of eHAV to nonenveloped virions
(1.227 to 1.283 g/cm3). While high, the total concentration of bile
acids within human gallbladder aspirates, well downstream of the
canalicular membrane, reaches 170 to 180 mM (39). Thus, the
transition to nonenveloped virion can be mediated entirely by
the detergent action of bile acids and, as indicated above, is most
likely to occur at or close to the canalicular membrane. Density
gradient analysis of virus present in bile collected from infected
DKO andMavs/mice confirmed this, as it revealed virus with a
range of densities extending from that of eHAV to that of the
naked particle (Fig. 5B, middle; see also Fig. S1B).
The phylogenetically unrelated hepatitis E virus (HEV) ap-
pears to be similarly wrapped in membranes when circulating in
the blood during acute infection (40), and, like HAV, it is shed in
feces as nonenveloped virions (41). The membrane of HEV may
be similarly removed by bile acids within the proximal biliary
tract. Both HAV and HEV are efficiently transmitted through the
fecal-oral route. These viruses are likely to benefit fromhaving two
distinct forms of virions: a naked, nonenveloped species that is
stable in the environment and optimized for transmission be-
tween hosts and a quasi-enveloped form that provides protection
against neutralizing antibodies and thus facilitates spread within
the host (6).
MATERIALS AND METHODS
Viruses. A noncytopathic, cell culture-adapted variant of the HM175
strain of HAV, HM175/p16 (20, 21), was grown in Huh-7.5 cells (42),
which were derived from a human hepatoma. Supernatant fluids were
clarified by low-speed centrifugation and frozen in aliquots as virus stock.
Cells. Caco-2 cells, a human colon adenoacarcinoma cell line (HTB-
37, obtained from the American Type Culture Collection), and Huh-7.5
cells (obtained from Charles Rice, Rockefeller University) were main-
tained in Dulbecco’s modified medium with Eagle’s salts (DMEM) sup-
plemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 100 U
penicillin, and 100g/ml streptomycin at 37°C in a 5% CO2 atmosphere.
A polarized subclone of HepG2 cells (clone N6) (13), a human hepatocel-
lular carcinoma cell line, was kindly provided by David Anderson, Burnet
Institute. The cells were grown inminimal essential medium (MEM) sup-
plemented with 10% FBS, 2 mM glutamine, 15 mMHEPES, 100 U peni-
cillin, and 100 g/ml streptomycin in plastic flasks coated with collagen
type I (Sigma Aldrich) at 37°C in a 5% CO2 atmosphere. FRhK-4 (fetal
rhesus kidney) cells were grown as described previously (5). AML12
(ATCC CRL-2254) cells were grown in DMEM/F-12 medium (Life Sci-
ence Technologies) supplemented with 10% FBS, 1 insulin-transferrin-
seleniums (Gibco), 40 ng/ml dexamethasone, and 2 mM glutamine at
37°C in a 5% CO2 atmosphere.
To obtain cell culture monolayers on permeable membranes, cells
were seeded on Transwell-COL tissue culture inserts (Corning) with a
4.7-cm2 growth area and 3.0-m pore size. Caco-2 cells were seeded at a
density of 3.2 105 cells/cm2 and then cultured for at least 10 days prior
to infection. HepG2-N6 cells were seeded at a density of 5 104 cells/cm2
in the growthmedium described above with the addition of 1%DMSO to
promote polarity (13) and were incubated for at least 18 days prior to
infection. The medium was replaced at intervals of 3 to 4 days. Confluent
monolayers were used for virus infection. Monolayer cells on glass slides
were used for antibody staining and were obtained by seeding 4-well
chamber slides (Nunc Lab-Tec II CC2) at the same density as the Trans-
well cultures described above, followed by incubation for 10 days (Caco-2
cells) or 18 days (HepG2-N6 cells). HepG2-N6 cells were grown on glass
slides in media containing 1% DMSO.
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Animal studies. Mice lacking expression of both type I and type II
interferon receptors (Ifnar1/ Ifngr1/ mice; referred to here as
“DKO”mice) or the innate immune signaling adaptor proteinmitochon-
drial antiviral-signaling protein (MAVS) (Mavs/) were infected by in-
travenous inoculation of either fourth- or fifth-mouse-passage HM175
HAV derived from infectedMavs/mouse liver (9). To characterize the
density of virus circulating during acute infection, blood was collected
from 2 to 4 mice by cardiac puncture using a 23-gauge needle at the peak
of viremia and allowed to clot and serumwas stored at80°C. For density
analysis, serum samples were pooled and subjected to isopycnic gradient
centrifugation as described below. Bile was collected from the gall blad-
ders of 2 to 3 mice using a 29-gauge needle at necropsy, pooled, and
subjected to isopycnic gradient centrifugation. Procedures formonitoring
infection in these mice were otherwise as described previously (9). All
animal studies were carried out with the approval of the University of
North Carolina Institutional Animal Care and Use Committee (IACUC).
Assessment of cell polarity. Caco-2 and HepG2-N6 cells grown on
glass slides as described above were fixed in 4% paraformaldehyde (PFA)
(Affymetrix) and then permeabilized in 0.25% Triton X-100 (Sigma Al-
drich) for 15 min and blocked with 10% normal goat serum–phosphate-
buffered saline (PBS) for 1 h at room temperature. Slides were incubated
with polyclonal rabbit antibody to tight junction protein 1 (TJP1, or
ZO-1) (Invitrogen) at a 1:100 dilution andmouse antibody to dipeptidyl-
peptidase 4 (DPP4, or CD26) (Abcam, Inc.) at a dilution of 1:200 in 3%
bovine serum albumin (BSA)–PBS overnight at 4°C (13, 43). Slides were
washed three times in PBS and incubated with Alexa-labeled secondary
Alexa-488 anti-rabbit antibody and Alexa-594 anti-mouse antibody (In-
vitrogen) in a solution of 3%BSA–PBS for 1 h at room temperature. Slides
were then counterstained with DAPI (4=,6-diamidino-2-phenylindole),
mounted with ProLong Gold Antifade Mountant (Life Technologies,
Inc.), sealed, and examinedwith anOlympus FV1000 laser-scanning con-
focal microscope. Images of xy and xz sections were collected using a 30
objective. z sections were compiled from 0.41-m-step images through
each x-y section and assembled by the use of Volocity software (Perkin-
Elmer).
Assessment of monolayer integrity. The integrity of Caco-2 and
HepG2-N6monolayers was assessed by measurements of permeability to
fluorescein isothiocyanate-conjugated dextran (FITC-dextran; Invitro-
gen) (molecular mass, 500 kDa) (13, 43). Briefly, 1.5 ml of medium con-
taining 100 g/ml FITC-dextran was added to the apical chamber of
Transwell-COL cultures in which the basolateral chamber contained
2.6mlmedium. Following 30, 60, or 90min of incubation at 37°C, 100-l
aliquots of the basolateral fluid were removed and examined for fluores-
cence with a Synergy 2 (Bio-Tek) Multi-Mode microplate reader (excita-
tion wavelength, 485 nm; emission wavelength, 528 nm). Diffusion into
the basolateral chamber was calculated as the percentage of total FITC-
dextran placed into the apical chamber per hour.
Virus infections. Monolayers grown on Transwell-COL inserts were
inoculated with 1  107 to 2  107 genome equivalents (GE) of HAV
(HM175/p16; predominantly eHAV) for 1 h at 36°C via the apical domain
(Caco-2 cells) or the basolateral domain (HepG2-N6 cells). HepG2-N6
cells were washed twice with medium prior to inoculation to remove
DMSO. Both cell types are permissive for HAV, but theirmodes of uptake
of virus differ. Caco-2 entry is largely restricted to the apical plasmamem-
brane (12), while viral entry occurs predominantly via the basolateral
membrane of HepG2-N6 cells, consistent with uptake of virus from the
bloodstream (13). Cells were extensively washed with medium on both
the apical and basolateral sides and were refed with fresh medium. Day 0
supernatant samples were immediately collected, and on each successive
day, the total apical and basolateral supernatants were collected for mea-
surements of HAV RNA levels by quantitative real-time RT-PCR (RT-
qPCR) and to determine the buoyant density of virions released into the
medium. The integrity of HAV-infected Caco-2 and HepG2-N6 mono-
layers was measured at 7 and 4 days after infection, respectively, by the
addition of FITC-dextran to the apical compartment, with samples col-
lected from the basolateral compartment 60 min later for analysis, as
described above. AML12 cells grown in a 6-well platewere inoculatedwith
1 107 GE of HM175/p16 virus for 1 h at 36°C, extensively washed, and
refed with fresh medium.
Measurements of transcytosis. HepG2-N6 monolayers grown on
Transwell-COL inserts were washed twice with medium to remove
DMSO and then inoculated with 1 108 GE of gradient-purified eHAV
or nonenveloped virions (HM175/p16) via the basolateral domain, fol-
lowed by incubation at either 36°C or 4°C. Apical supernatants were col-
lected at hourly intervals for measurement of HAV RNA by RT-qPCR,
with the cells refed with prewarmed or precooled fresh medium. The
integrity of the monolayers was measured 3 h after inoculation by the
addition of FITC-dextran to the apical compartment, with samples col-
lected from the basolateral compartment 60 min later for analysis as de-
scribed above.
RT-qPCR for HAV RNA. RNA from culture supernatants and gradi-
ent fractions was extracted with a QiaAmp viral RNA isolation kit
(Qiagen) (5). RT-qPCR analysis was carried out using an iScript One Step
RT-PCR kit for probes and an iTaq Universal Probes one-step kit (Bio-
Rad)with a CFX96 real-time PCRdetection system (Bio-Rad). HAVRNA
levels were determined by reference to a standard curve obtained with
synthetic HAV RNA. Primers targeted sequences in the 5= untranslated
RNA segment of the genome (5=-GGTAGGCTACGGGTGAAAC-3= and
5=-AACAACTCACCAATATCCGC-3=) (35). The 6-carboxyfluorescein/
6-carboxytetramethylrhodamine (FAM/TAMRA) probe was 5=-CTTAG
GCTAATACTTCTA TGAAGAGATGC-3=.
Isopycnic gradient ultracentrifugation. Cell culture supernatants
were centrifuged at 2,000 rpm for 3 min to remove debris and then con-
centrated using a filtration device with a 100-K molecular weight limit
(Amicon). The concentrated virus was loaded onto an 8% to 40% iodix-
anol (OptiPrep; Sigma Aldrich) step gradient in a 5-ml ultracentrifuge
tube (BeckmanCoulter, Inc.) and centrifuged at 37,000 rpm in aBeckman
SW55i rotor for 24 h at 4°C in a Beckman Optina LE-80K ultracentrifuge
(5). Approximately 20 fractions were collected from the top of the gradi-
ent, and the HAV RNA content of each was quantified by RT-PCR. The
density of gradient fractions was determined by refractometry.
Preparation of purified eHAV and HAV. Culture supernatants from
HAV-infected Huh-7.5 cells were centrifuged at 1,000  g for 10 min at
4°C to remove debris and then further clarified by centrifugation twice
at 10,000 g for 30min. Virus was concentrated by ultracentrifugation at
100,000 g in a Superspin 640 rotor for 1 h at 4°C in a Sorvall Ultra-80
ultracentrifuge (5). The resulting pellet was resuspended in PBS and then
loaded onto an 8% to 40% iodixanol step gradient and ultracentrifuged as
described above. Approximately 20 fractions were collected, and theHAV
RNA content and density of each fraction were determined. Fractions
containing virus with the appropriate buoyant density (for eHAV, ap-
proximately 1.08 g/cm3, fractions 8 to 11; for nonenvelopedHAV virions,
1.22 g/cm3, fractions 17 to 20) (5) were combined and subjected to filtra-
tion (Amicon) (100-Kmolecularweight limit) to remove iodixanol and to
exchange the buffer to PBS. eHAV and HAV preparations were stored at
80°C until use.
Treatment of eHAVwith bile acids. Stock solutions were prepared by
dissolving chenodeoxycholic acid (CDCA; Sigma-Aldrich) in DMSO at
240 mM (100 mg/ml) and taurocholic acid (TCA, Sigma-Aldrich) in PBS
at 186 mM (100 mg/ml) and stored at 20°C. Gradient-purified eHAV
(approximately 5  107 GE) was incubated in 24 mM CDCA–10%
DMSO–PBS, 93 mM or 930 mM (freshly prepared) TCA–PBS, 10%
DMSO–PBS, or PBS alone for 2 h at 37°C and then subjected to repeat
isopycnic ultracentrifugation in iodixanol gradients as described above.
The resulting fractions were assayed byHAV-specific RT-qPCR, and den-
sity was determined by refractometry. To assess the effect of bile acids on
infectivity, fractions were combined and concentrated and bile acids were
removed by diafiltration (100-kDa exclusion) followed by infectivity assay
and antigen detection ELISA.
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HAV capsid antigen ELISA. Virus samples (approximately 2  107
GE) were captured by human convalescent antibody (JC virus plasma)
coated on a 96-well polystyrene plate (5). Anti-HAV capsid monoclonal
antibody K24F2 (Commonwealth Serum Laboratories) was incubated in
the wells of the plate at room temperature for 1 h, followed by incubation
with horseradish peroxidase-conjugated goat anti-mouse antibody
(Southern Biotech) at room temperature for 1 h. Following the addition
of substrate (3,3=,5=,5=-tetramethylbezidine), the optical density at 450
nm (OD450) was determined using a Synergy 2 (BioTek) microplate
reader.
Infrared fluorescent immunofocus assay. Infectious HAVwas quan-
tified by an infrared fluorescent immunofocus assay (IR-IFA) in FRhK-4
cells (44). Briefly, virus samples were inoculated onto FRhK-4 cell mono-
layers in 12-well plates and allowed to adsorb for 2 h at 36°C prior to the
addition ofmedium containing 1%methyl cellulose and 1%FBS. Follow-
ing 10 days of incubation at 37°C in a 5% CO2 atmosphere, the medium
was removed and cells were fixed with 4% PFA. The cell sheet was perme-
abilized with 0.25%Triton X-100, blocked with 10% normal goat serum–
PBS, and incubated with anti-HAV mouse monoclonal antibody K32F2
(Commonwealth Serum Laboratories) diluted 1:600 in 3% BSA–PBS
overnight at 4°C. The cells were washed with PBS and incubated for 1 h at
room temperature with IRDye 680LT anti-mouse antibody (Li-CORBio-
science) (1g/ml)–3%BSA–PBS. To visualize viral replication foci, plates
were scanned with an Odyssey infrared imaging system (Li-COR Biosci-
ence).
Statistics. Statistical significance was assessed with various tests as de-
scribed in Results, with calculations carried out using the Prism 6 forMac
OS X software package. A P value of less than 0.05 was considered signif-
icant.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
lookup/suppl/doi:10.1128/mBio.01998-16/-/DCSupplemental.
Figure S1, TIF file, 0.3 MB.
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